Evidence suggests that TP53 mutations are prevalent in fibroblast-like synoviocytes in rheumatoid arthritis, with AID-positive cells exhibiting a heightened frequency of somatic TP53 mutations [50]. Here, AICDA is linked to rheumatoid arthritis.